Bruker Corp (NASDAQ: BRKR) kicked off on Monday, up 7.30% from the previous trading day, before settling in for the closing price of $37.52. Over the past 52 weeks, BRKR has traded in a range of $34.10-$79.78.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 10.58% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 0.93%. With a float of $103.11 million, this company’s outstanding shares have now reached $151.52 million.
In an organization with 11396 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 49.0%, operating margin of 8.7%, and the pretax margin is 6.15%.
Bruker Corp (BRKR) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Bruker Corp is 31.95%, while institutional ownership is 81.81%. The most recent insider transaction that took place on Mar 10 ’25, was worth 23,698. In this transaction Chief Accounting Officer of this company bought 500 shares at a rate of $47.40, taking the stock ownership to the 3,472 shares. Before that another transaction happened on Feb 18 ’25, when Company’s PRESIDENT & CEO bought 20,000 for $50.92, making the entire transaction worth $1,018,330. This insider now owns 38,459,563 shares in total.
Bruker Corp (BRKR) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 0.93% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.52% during the next five years compared to -9.69% drop over the previous five years of trading.
Bruker Corp (NASDAQ: BRKR) Trading Performance Indicators
Take a look at Bruker Corp’s (BRKR) current performance indicators. Last quarter, stock had a quick ratio of 0.74. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.77. Likewise, its price to free cash flow for the trailing twelve months is 34.94.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.53, a number that is poised to hit 0.44 in the next quarter and is forecasted to reach 2.74 in one year’s time.
Technical Analysis of Bruker Corp (BRKR)
Let’s dig in a bit further. During the last 5-days, its volume was 3.95 million. That was better than the volume of 2.15 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 32.48%. Additionally, its Average True Range was 2.37.
During the past 100 days, Bruker Corp’s (BRKR) raw stochastic average was set at 20.17%, which indicates a significant decrease from 53.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 52.26% in the past 14 days, which was higher than the 51.56% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $41.65, while its 200-day Moving Average is $55.50. However, in the short run, Bruker Corp’s stock first resistance to watch stands at $42.19. Second resistance stands at $44.12. The third major resistance level sits at $45.70. If the price goes on to break the first support level at $38.68, it is likely to go to the next support level at $37.10. Assuming the price breaks the second support level, the third support level stands at $35.17.
Bruker Corp (NASDAQ: BRKR) Key Stats
The company with the Market Capitalisation of 6.10 billion has total of 151,532K Shares Outstanding. Its annual sales at the moment are 3,366 M in contrast with the sum of 113,100 K annual income. Company’s last quarter sales were recorded 979,600 K and last quarter income was 13,700 K.
